We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AstroNova Incurs Loss in Q4, Narrows Y/Y on Aerospace Demand
Read MoreHide Full Article
Shares of AstroNova, Inc. (ALOT - Free Report) have gained 11.3% since the company reported its earnings for the quarter ended Jan. 31, 2026, outperforming the S&P 500 index’s 3.3% increase over the same period. The stock has shown even stronger momentum over a longer horizon, advancing 47.2% in the past month compared with the S&P 500’s 6.1% rise.
AstroNova incurred a fourth-quarter 2026 net loss of 15 cents per share, narrower than a loss of $2.07 per share in the prior-year quarter.
Revenue of $37.5 million denoted a 0.5% year-over-year increase, reflecting modest growth driven primarily by its Product Identification (Product ID) segment.
Net loss narrowed significantly to $1.1 million from a loss of $15.6 million in the prior-year quarter, which had been impacted by a $13.4 million goodwill impairment charge.
Adjusted EBITDA for the fourth quarter increased 18.3% to $3.3 million.
Performance across AstroNova’s two segments was mixed. Product ID revenue rose 2.5% year over year to $26.3 million in the fourth quarter, supported by strong aftermarket demand, which accounted for roughly 80% of segment sales. However, the segment continued to post an operating loss, albeit significantly reduced from the prior year due to the absence of impairment charges. Aerospace revenue declined 4.1% to $11.2 million, primarily due to project timing, but segment operating profit increased 24% to $2.3 million, driven by a favorable product mix.
Orders and backlog trends provided additional insight into demand. Total quarterly orders rose 6.5% to $41.1 million, with Product ID orders up $2.9 million year over year and a book-to-bill ratio of 104%, signaling improving commercial traction. Aerospace orders also remained robust, with a book-to-bill ratio of 122%, reflecting sustained demand from aircraft OEMs.
Management Commentary
Management characterized fiscal 2026 as a “reset period,” particularly in the second half, focusing on stabilizing operations, improving cash generation, and reducing debt. Leadership emphasized progress in repositioning the Product ID business through a refined go-to-market strategy and better alignment of resources toward high-value verticals such as healthcare, industrial and chemical markets.
The Aerospace segment remained a bright spot, benefiting from strong demand and increasing adoption of the ToughWriter product line, which now accounts for more than 80% of flight deck printer shipments. Management also highlighted cultural and operational changes, including improved analytics, talent realignment, and enhanced customer focus, as key drivers of future performance.
Drivers of Financial Performance
Several factors influenced the quarter’s results. Revenue growth was supported by $0.6 million in tariff mitigation actions and a $0.8 million benefit from foreign currency translation. However, gross profit declined 7.4% year over year, and gross margin contracted by 250 basis points to 30.2%, reflecting lower volume and unfavorable product mix.
On the positive side, operating expenses fell sharply due to the absence of prior-year impairment charges, contributing to a return to near breakeven operating income. Additionally, the company improved cash generation, with quarterly operating cash flow rising to $3.7 million from $2.5 million, driven by lower working capital requirements, particularly inventory reductions.
Balance sheet strengthening was another notable development. AstroNova reduced debt by $2.7 million during the quarter and $9.1 million for the full year, while maintaining liquidity of $15.9 million.
Fiscal 2026 Update
For the fiscal year, revenues declined slightly by 0.5% to $150.5 million.
Net loss narrowed to $2.4 million, or 31 cents per share, from $14.5 million, or $1.93 per share, a year earlier.
Adjusted EBITDA for the year increased 2.8% to $12.7 million, highlighting underlying operational improvements despite margin pressure.
Outlook and Guidance
Looking ahead, management expects mid-single-digit revenue growth in fiscal 2027, along with expansion in adjusted EBITDA margins. Growth in Aerospace is anticipated to be supported by rising aircraft production and improved product mix. A key tailwind will be the expiration of a major royalty obligation in the third quarter of fiscal 2027, expected to add approximately $2 million annually to gross profit beginning in the fourth quarter.
In Product ID, the focus remains on converting a growing commercial pipeline into consistent revenue growth while improving operational efficiency and profitability.
Other Developments
AstroNova disclosed that it is evaluating strategic alternatives, which may include a sale, merger, or other financial transactions aimed at enhancing shareholder value. The company noted that this review is in early stages and no specific outcomes have been determined.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
AstroNova Incurs Loss in Q4, Narrows Y/Y on Aerospace Demand
Shares of AstroNova, Inc. (ALOT - Free Report) have gained 11.3% since the company reported its earnings for the quarter ended Jan. 31, 2026, outperforming the S&P 500 index’s 3.3% increase over the same period. The stock has shown even stronger momentum over a longer horizon, advancing 47.2% in the past month compared with the S&P 500’s 6.1% rise.
AstroNova incurred a fourth-quarter 2026 net loss of 15 cents per share, narrower than a loss of $2.07 per share in the prior-year quarter.
Revenue of $37.5 million denoted a 0.5% year-over-year increase, reflecting modest growth driven primarily by its Product Identification (Product ID) segment.
Net loss narrowed significantly to $1.1 million from a loss of $15.6 million in the prior-year quarter, which had been impacted by a $13.4 million goodwill impairment charge.
Adjusted EBITDA for the fourth quarter increased 18.3% to $3.3 million.
AstroNova, Inc. Price, Consensus and EPS Surprise
AstroNova, Inc. price-consensus-eps-surprise-chart | AstroNova, Inc. Quote
Segment Performance and Business Metrics
Performance across AstroNova’s two segments was mixed. Product ID revenue rose 2.5% year over year to $26.3 million in the fourth quarter, supported by strong aftermarket demand, which accounted for roughly 80% of segment sales. However, the segment continued to post an operating loss, albeit significantly reduced from the prior year due to the absence of impairment charges. Aerospace revenue declined 4.1% to $11.2 million, primarily due to project timing, but segment operating profit increased 24% to $2.3 million, driven by a favorable product mix.
Orders and backlog trends provided additional insight into demand. Total quarterly orders rose 6.5% to $41.1 million, with Product ID orders up $2.9 million year over year and a book-to-bill ratio of 104%, signaling improving commercial traction. Aerospace orders also remained robust, with a book-to-bill ratio of 122%, reflecting sustained demand from aircraft OEMs.
Management Commentary
Management characterized fiscal 2026 as a “reset period,” particularly in the second half, focusing on stabilizing operations, improving cash generation, and reducing debt. Leadership emphasized progress in repositioning the Product ID business through a refined go-to-market strategy and better alignment of resources toward high-value verticals such as healthcare, industrial and chemical markets.
The Aerospace segment remained a bright spot, benefiting from strong demand and increasing adoption of the ToughWriter product line, which now accounts for more than 80% of flight deck printer shipments. Management also highlighted cultural and operational changes, including improved analytics, talent realignment, and enhanced customer focus, as key drivers of future performance.
Drivers of Financial Performance
Several factors influenced the quarter’s results. Revenue growth was supported by $0.6 million in tariff mitigation actions and a $0.8 million benefit from foreign currency translation. However, gross profit declined 7.4% year over year, and gross margin contracted by 250 basis points to 30.2%, reflecting lower volume and unfavorable product mix.
On the positive side, operating expenses fell sharply due to the absence of prior-year impairment charges, contributing to a return to near breakeven operating income. Additionally, the company improved cash generation, with quarterly operating cash flow rising to $3.7 million from $2.5 million, driven by lower working capital requirements, particularly inventory reductions.
Balance sheet strengthening was another notable development. AstroNova reduced debt by $2.7 million during the quarter and $9.1 million for the full year, while maintaining liquidity of $15.9 million.
Fiscal 2026 Update
For the fiscal year, revenues declined slightly by 0.5% to $150.5 million.
Net loss narrowed to $2.4 million, or 31 cents per share, from $14.5 million, or $1.93 per share, a year earlier.
Adjusted EBITDA for the year increased 2.8% to $12.7 million, highlighting underlying operational improvements despite margin pressure.
Outlook and Guidance
Looking ahead, management expects mid-single-digit revenue growth in fiscal 2027, along with expansion in adjusted EBITDA margins. Growth in Aerospace is anticipated to be supported by rising aircraft production and improved product mix. A key tailwind will be the expiration of a major royalty obligation in the third quarter of fiscal 2027, expected to add approximately $2 million annually to gross profit beginning in the fourth quarter.
In Product ID, the focus remains on converting a growing commercial pipeline into consistent revenue growth while improving operational efficiency and profitability.
Other Developments
AstroNova disclosed that it is evaluating strategic alternatives, which may include a sale, merger, or other financial transactions aimed at enhancing shareholder value. The company noted that this review is in early stages and no specific outcomes have been determined.